Sjögren's Syndrome Is Associated With an Increased Risk of Vitiligo

Area of Science:

• Rheumatology
• Dermatology
• Epidemiology

Background:

• Sjögren's syndrome (SS) is a chronic autoimmune disease with limited studied correlations to vitiligo.
• Understanding the association between SS and vitiligo risk is crucial for patient management and research.

Purpose of the Study:

• To investigate the association between Sjögren's syndrome and the risk of developing vitiligo.
• To analyze comorbidity profiles and the impact of medications on this association.

Main Methods:

• Retrospective, population-based analysis using Taiwan's National Health Insurance Research Database (2008-2019).
• Propensity score matching was employed for cohort analysis.
• Cox proportional hazards models were used to determine the incidence of vitiligo.

Main Results:

• Individuals with SS demonstrated a 1.90-fold increased risk of developing vitiligo compared to controls.
• Risk was higher in specific age groups (40-59 and 60-79 years) and females.
• Comorbidities like hyperthyroidism and spondylarthritis increased risk, while systemic corticosteroids showed a protective effect.

Conclusions:

• Sjögren's syndrome is significantly linked to an elevated risk of vitiligo development.
• Further research is needed to understand the specific mechanisms driving this association.